Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/61228
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTaylor, Jacken
dc.contributor.authorAzimi, Imanen
dc.contributor.authorMonteith, Gregoryen
dc.contributor.authorBebawy, Maryen
dc.date.accessioned2024-07-05T09:17:26Z-
dc.date.available2024-07-05T09:17:26Z-
dc.date.issued2020-09-
dc.identifier.citationJournal of Extracellular Vesicles, 9(1), p. 1-14en
dc.identifier.issn2001-3078en
dc.identifier.urihttps://hdl.handle.net/1959.11/61228-
dc.description.abstract<p>Extracellular vesicles (EVs) are small membrane vesicles that serve as important intercellular signalling intermediaries in both malignant and non-malignant cells. For EVs formed by the plasma membrane, their biogenesis is characterized by an increase in intracellular calcium followed by successive membrane and cytoskeletal changes. EV-production is significantly higher in malignant cells relative to non-malignant cells and previous work suggests this is dependent on increased calcium mobilization and activity of calpain. However, calcium-signalling pathways involved in malignant and non-malignant EV biogenesis remain unexplored. Here we demonstrate; malignant cells have high basal production of plasma membrane EVs compared to non-malignant cells and this is driven by a calcium–calpain dependent pathway. Resting vesiculation in malignant cells occurs via mobilization of calcium from endoplasmic reticulum (ER) stores rather than from the activity of plasma membrane calcium channels. In the event of ER store depletion however, the store-operated calcium entry (SOCE) pathway is activated to restore ER calcium stores. Depleting both ER calcium stores and blocking SOCE, inhibits EV biogenesis. In contrast, calcium signalling pathways are not activated in resting non-malignant cells. Consequently, these cells are relatively low vesiculators in the resting state. Following cellular activation however, an increase in cytosolic calcium and activation of calpain increase in EV biogenesis. These findings contribute to furthering our understanding of extracellular vesicle biogenesis. As EVs are key mediators in the intercellular transfer of deleterious cancer traits such as cancer multidrug resistance (MDR), understanding the molecular mechanisms governing their biogenesis in cancer is the crucial first step in finding novel therapeutic targets that circumvent EV-mediated MDR.</p>en
dc.languageenen
dc.publisherJohn Wiley & Sons Ltden
dc.relation.ispartofJournal of Extracellular Vesiclesen
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.titleCa2+ mediates extracellular vesicle biogenesis through alternate pathways in malignancyen
dc.typeJournal Articleen
dc.identifier.doi10.1080/20013078.2020.1734326en
dc.identifier.pmid32194926en
dcterms.accessRightsUNE Greenen
local.contributor.firstnameJacken
local.contributor.firstnameImanen
local.contributor.firstnameGregoryen
local.contributor.firstnameMaryen
local.profile.schoolSchool of Psychologyen
local.profile.emailmbebawy@une.edu.auen
local.output.categoryC1en
local.record.placeauen
local.record.institutionUniversity of New Englanden
local.publisher.placeUnited Kingdomen
local.identifier.runningnumber1734326en
local.format.startpage1en
local.format.endpage14en
local.peerreviewedYesen
local.identifier.volume9en
local.identifier.issue1en
local.access.fulltextYesen
local.contributor.lastnameTayloren
local.contributor.lastnameAzimien
local.contributor.lastnameMonteithen
local.contributor.lastnameBebawyen
dc.identifier.staffune-id:mbebawyen
local.profile.orcid0000-0003-2606-921Xen
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.identifier.unepublicationidune:1959.11/61228en
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
local.title.maintitleCa2+ mediates extracellular vesicle biogenesis through alternate pathways in malignancyen
local.relation.fundingsourcenoteGRM was supported by the Mater Foundation. The Translational Research Institute is supported by a grant from the Australian Government.en
local.output.categorydescriptionC1 Refereed Article in a Scholarly Journalen
local.search.authorTaylor, Jacken
local.search.authorAzimi, Imanen
local.search.authorMonteith, Gregoryen
local.search.authorBebawy, Maryen
local.open.fileurlhttps://rune.une.edu.au/web/retrieve/2845175d-5f86-41bd-bdb9-942a61f6cf5fen
local.uneassociationNoen
local.atsiresearchNoen
local.sensitive.culturalNoen
local.year.published2020en
local.fileurl.openhttps://rune.une.edu.au/web/retrieve/2845175d-5f86-41bd-bdb9-942a61f6cf5fen
local.fileurl.openpublishedhttps://rune.une.edu.au/web/retrieve/2845175d-5f86-41bd-bdb9-942a61f6cf5fen
local.subject.for20203208 Medical physiologyen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.date.moved2024-07-19en
Appears in Collections:Journal Article
School of Psychology
Files in This Item:
2 files
File Description SizeFormat 
openpublished/Ca2Bebawy2020JournalArticle.pdfPublished version852.27 kBAdobe PDF
Download Adobe
View/Open
Show simple item record

SCOPUSTM   
Citations

72
checked on Dec 21, 2024
Google Media

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons